Latest Pharmaceutical sciences Stories

WESTON, FL, May 10, 2013 /PRNewswire/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 21 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, NDC number 60505-0773-00 to the hospital / healthcare provider /user level. The impacted lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams may show precipitation / crystallization in IV bag or IV line after reconstitution....

NEW YORK, May 10, 2013 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of a class (the "Class") of purchasers of Ventrus Biosciences, Inc. ("Ventrus" or the "Company") (NASDAQ: VTUS) securities between December 17, 2010 and June 25, 2012 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO ) Ventrus is a development stage...

"The market is potentially huge... rising to $5 billion by 2018" HOLLYWOOD, Calif., May 10, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced today that their company has been featured in an article in Bloomberg Businessweek. The report profiled the company, the management team, and the company's core product. "The devices sit behind sales counters...

SAN DIEGO, May 10, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013, at 2:20 p.m. Pacific Time (5:20 p.m. Eastern Time), at the Encore at the Wynn Las Vegas Hotel in Las Vegas, Nevada. A live audio webcast of the presentation will be available under the investor relations section of Arena's website at...

CUPERTINO, Calif., May 10, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing. Pfizer's disclosure is as follows: "In 2005, King Pharmaceuticals, Inc. (King) entered into an agreement with Pain Therapeutics, Inc. (PT) to develop and commercialize Remoxy. In August 2008, the FDA accepted the NDA for Remoxy that had been submitted by King and PT. In December 2008, the FDA issued a...

Conference Call and Webcast at 11:00 a.m. Eastern Time THE WOODLANDS, Texas, May 10, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2013. "In the first quarter of 2013, we continued to progress our clinical pipeline on multiple fronts. Most...

Ms. Barchuk and her husband provide quality janitorial services to pharmaceutical companies WINTER GARDEN, Fla., May 10, 2013 /PRNewswire/ -- Shelia Barchuk, Owner of Custom Care Janitorial Services, was recently named a VIP member of Worldwide Who's Who. This special distinction honors individuals who have shown exceptional commitment to achieving personal and professional success. Custom Care is a commercial janitorial company that specializes in cleaning the facilities of...

TAINAN, Taiwan, May 10, 2013 /PRNewswire/ -- ScinoPharm Taiwan Ltd. (TSE: 1789.TW) and Coland Holdings Ltd. (TSE: 4144.TW) announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China. Several Active Pharmaceutical Ingredients (APIs) have been initially selected for development and future sales as injectable formulation products from the list of ScinoPharm-developed APIs. This will allow the companies to compete within...

WCCT Global, a contract research organization headquartered in Southern California, has been awarded the 2013 Cypress Award. Costa Mesa, CA (PRWEB) May 08, 2013 Contract research organization WCCT Global has been awarded the 2013 Cypress Award for the second consecutive year. This has been awarded due to research work that WCCT Global has conducted over the past year and the growth within the organization. For 2013, only 1.4% of all who received this award have received this for two...

Medrio proudly announces Provonix to join the Medrio Partner Program. San Francisco, CA and Mullica Hill, NJ (PRWEB) May 08, 2013 Provonix, a customer-focused CRO providing innovative clinical trial solutions for pharmaceutical, biotechnology, and medical device companies, today joined the Medrio Partner Program after earning accreditation in Medrio’s eClinical Software as a Software (SaaS) platform. The Medrio Partner Program is a collaborative effort aligning Medrio resources with...